Insilico Medicine Hong Kong Limited

Hong Kong
Service Company

Insilico Medicine is an artificial intelligence (AI)-driven pharma-technology company. It provides AI solutions for drug discovery, research, and development. The company delivers a range of generative adversarial networks (GANs) and reinforcement learning approaches to identify protein targets, generate molecular structures, and generate synthetic data. It was founded in 2014 and is based in Hong... See more

Company Information

Nature of Business:
Service Company
Major Markets:
Eastern Europe, North America, Western Europe
Main Categories:
Technology, R&D
Number of Staff (HK):
201 - 500
Year of Establishment:
2014

Company Award/ Qualification

Hong Kong ICT Awards 2023 – Smart Business (Emerging Technologies) Silver Award

Deloitte Technology Fast Leader 2023 Hong Kong – Fast 15

Deloitte Technology Fast Leader 2023 China – Fast 50

Deloitte Technology Fast Leader 2023 Greater Bay Area – Fast 40

Asia’s Most Valuable Company in Hong Kong Award 2023 - Best AI Applications of the Year

Hong Kong Business Technology Excellence Awards 2023 (AI-Pharmaceuticals)

Asia’s Most Valuable Company in Hong Kong 2022 – Asia’s Most Innovative Biotechnology Company

Hong Kong Business Technology Excellence Awards 2022 ( AI-Pharmaceuticals)

Hong Kong’s Most Outstanding Leaders Awards 2021

Contact

Contact Person:
Mr Frank Pun
Position:
Head Of Hong Kong Office
Office Address:
Unit 310, 3/F, Building 8W, Phase 2, 8 Science Park West Avenue, Pak Shek Kok, Tai Po, New Territories, Hong Kong
Country/ Region:
Hong Kong
You may also like